SB18-080 Summary

• Creates the "Colorado Wholesale Importation of Prescription Drugs Act" requiring the Department of Health Care Policy and Financing to design a program importing prescription pharmaceuticals from Canada for resale to Colorado residents.

• Program design must address drug safety, cost savings, Canadian supplier selection, drug testing, pricing limits, profit margins, carrier participation, and compliance with federal track-and-trace requirements under 21 U.S.C. § 384.

• Department must submit draft report by January 1, 2019, hold at least two public hearings (one in Denver, one in Western Colorado), and submit final report by April 15, 2019 to relevant legislative committees.

• Executive Director must submit program design to U.S. Department of Health and Human Services Secretary by May 1, 2019 for approval; implementation sections take effect only upon Secretary approval that the program complies with federal law.

• Department must adopt financing mechanism for administrative costs (such as per-prescription fees) without significantly reducing consumer savings, and annually report on program participation, prescriptions dispensed, and estimated savings.